Proceedings: Iontophoretic study of the central anticholinergic properties of BRL 1288.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001001:Anura; D001285:Atropine / Q000494:pharmacology; D001561:Benzilates / Q000494:pharmacology*; D002415:Cats; D005021:Ethylamines / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists; D066298:In Vitro Techniques; D007478:Iontophoresis; D010276:Parasympatholytics / Q000494:pharmacology*; D011343:Procaine / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D012584:Sciatic Nerve / Q000187:drug effects
D000978:Antiparkinson Agents; D001561:Benzilates; D005021:Ethylamines; D018691:Excitatory Amino Acid Antagonists; D010276:Parasympatholytics; D011437:Propylamines; D011343:Procaine; D001285:Atropine; D000109:Acetylcholine